Found: 6
Select item for more details and to access through your institution.
Dystrophin is a tumor suppressor in human cancers with myogenic programs.
- Published in:
- Nature Genetics, 2014, v. 46, n. 6, p. 601, doi. 10.1038/ng.2974
- By:
- Publication type:
- Article
Optimizing Ex Vivo CAR-T Cell-Mediated Cytotoxicity Assay through Multimodality Imaging.
- Published in:
- Cancers, 2024, v. 16, n. 14, p. 2497, doi. 10.3390/cancers16142497
- By:
- Publication type:
- Article
GAS-Luc2 Reporter Cell Lines for Immune Checkpoint Drug Screening in Solid Tumors.
- Published in:
- Cancers, 2024, v. 16, n. 11, p. 1965, doi. 10.3390/cancers16111965
- By:
- Publication type:
- Article
CRISPR/Cas9 Edited RAS & MEK Mutant Cells Acquire BRAF and MEK Inhibitor Resistance with MEK1 Q56P Restoring Sensitivity to MEK/BRAF Inhibitor Combo and KRAS G13D Gaining Sensitivity to Immunotherapy.
- Published in:
- Cancers, 2022, v. 14, n. 21, p. 5449, doi. 10.3390/cancers14215449
- By:
- Publication type:
- Article
Fibroblast-like synoviocytes in inflammatory arthritis pathology: the emerging role of cadherin-11.
- Published in:
- Immunological Reviews, 2010, v. 233, n. 1, p. 256, doi. 10.1111/j.0105-2896.2009.00854.x
- By:
- Publication type:
- Article
Integrins traffic rapidly via circular dorsal ruffles and macropinocytosis during stimulated cell migration.
- Published in:
- Journal of Cell Biology, 2011, v. 193, n. 1, p. 61, doi. 10.1083/jcb.201007003
- By:
- Publication type:
- Article